Effects of Esmolol Infusion on Cardiovascular Parameters and Quality of General Anaesthesia in Younger and Older Patients
Abstract
Background: Esmolol is a cardioselective β-adrenergic antagonist that is used during general anaesthesia to blunt the sympathetic reflex tachycardia and hypertension. The aim of the study was to investigate whether the potential beneficial and adverse effects of esmolol differ depending on the patient age.
Methods: A total of 50 ASA I/II patients scheduled for elective upper abdominal surgery were divided in two groups: younger (patients aged up to 35 years) and older (patients older than 65). After premedication with diazepam, they were infused with esmolol during the first 5 min at a rate of 0.3 mg/kg/min and 0.1 mg/kg/min thereafter. Anaesthesia was induced with thiopental sodium 3-5 mg/kg intravenously (iv) and fentanyl 1.5 µg/kg iv. Tracheal intubation was facilitated with suxamethonium 1-2 mg/kg iv. Long-term neuromuscular blockade was induced with pancuronium bromide 0.07 mg/kg iv bolus and maintained with incremental iv boluses of 0.01 mg/kg. Inhalational anaesthesia was maintained with a mixture of oxygen and nitrous oxide (O2/N2O) 2 : 1.
Results: The systolic blood pressure remained constant during the intubation phase in the group of older patients, at the same time being around 89 % of the pre-induction values, while in younger patients it rose up to 100 %. During the same phase of anaesthesia, the diastolic blood pressure in older patients remained at about 91 %, while in younger patients it rose up to 107 % of the pre-induction values. The consumption of drugs and the speed and quality of the recovery from anaesthesia did not differ between the two groups of patients.
Conclusion: Infusion of esmolol contributes to the concept of general balanced anaesthesia in elective patients scheduled for upper abdominal surgery equally in younger and older patients.
References
Zaroslinski J, Borgman RJ, O’Donnell JP, Anderson WG, Erhardt PW, Kam ST, et al. Ultra-short acting beta-blockers: a proposal for the treatment of the critically ill patient. Life Sci 1982 Aug 30;31(9):899-907.
Sum CY, Yacobi A, Kartzinel R, Stampfli H, Davis CS, Lai CM. Kinetics of esmolol, an ultrashort-acting beta blocker, and of its major metabolite. Clin Pharmacol Ther 1983 Oct;34(4):427-34.
De Bruijn NP, Reves JG, Croughwell N, Clements F, Drissel DA. Pharmacokinetics of esmolol in anesthetized patients receiving chronic beta blocker therapy. Anesthesiology 1987 Mar;66(3):323-6.
Quon CY, Mai K, Patil G, Stampfli HF. Species differences in the stereoselective hydrolysis of esmolol by blood esterases. Drug Metab Dispos 1988 May;16(3):425-8.
Reilly CS, Wood M, Koshakji RP, Wood AJ. Ultra-short-acting beta-blockade: a comparison with conventional beta-blockade. Clin Pharmacol Ther 1985 Nov;38(5):579-85.
Jahn P, Eckrich B, Schneidrowski B, Volz-Zang C, Schulte B, Mutschler E, et al. Beta 1-adrenoceptor subtype selective antagonism of esmolol and its major metabolite in vitro and in man. Investigations using tricresylphosphate as red blood cell inhibitor. Arzneimittelforschung 1995 May;45(5):536-41.
Anderson S, Blanski L, Byrd RC, Das G, Engler R, Laddu A, et al. Comparison of the efficacy and safety of esmolol, a short-acting beta blocker, with placebo in the treatment of supraventricular tachyarrhythmias. The Esmolol vs Placebo Multicenter Study Group. Am Heart J 1986 Jan;111(1):42-8.
Capuzzo M, Verri M, Alvisi R. Hemodynamic responses to laryngoscopy and intubation: etiological or symptomatic prevention? Minerva Anestesiol 2010 Mar;76(3):173-4.
Guney A, Kaya FN, Yavascaoglu B, Gurbet A, Selmi NH, Kaya S, et al. Comparison of esmolol to nitroglycerine in controlling hypotension during nasal surgery. Eurasian J Med 2012 Aug;44(2):99-105.
Bajracharya JL, Subedi A, Pokharel K, Bhattarai B. The effect of intraoperative lidocaine versus esmolol infusion on postoperative analgesia in laparoscopic cholecystectomy: a randomized clinical trial. BMC Anesthesiol 2019;19:198. doi: 10.1186/s12871-019-0874-8.
Girard D, Shulman BJ, Thys DM, Mindich BP, Mikula SK, Kaplan JA. The safety and efficacy of esmolol during myocardial revascularization. Anesthesiology 1986 Aug;65(2):157-64.
Efe EM, Bilgin BA, Alanoglu Z, Akbaba M, Denker C. Comparison of bolus and continuous infusion of esmolol on hemodynamic response to laryngoscopy, endotracheal intubation and sternotomy in coronary artery bypass graft. Rev Bras Anestesiol 2014 Jul-Aug;64(4):247-52.
Parikh DA, Garg SN, Dalvi NP, Surana PP, Sannakki D, Tendolkar BA. Outcome of four pretreatment regimes on hemodynamics during electroconvulsive therapy: a double-blind randomized controlled crossover trial. Ann Card Anaesth 2017 Jan-Mar;20(1):93-9.
Pemberton P, Veenith T, Snelson C, Whitehouse T. Is it time to beta block the septic patient? Biomed Res Int 2015;2015:424308. doi: 10.1155/2015/424308.
Vijayakumar HR, Thomas WO, Ferrara JJ. Peri-operative management of severe thyrotoxicosis with esmolol. Anaesthesia 1989 May;44(5):406-8.
Isley WL, Dahl S, Gibbs H. Use of esmolol in managing a thyrotoxic patient needing emergency surgery. Am J Med 1990 Jul;89(1):122-3.
Knighton JD, Crosse MM. Anaesthetic management of childhood thyrotoxicosis and the use of esmolol. Anaesthesia 1997 Jan;52(1):67-70.
Duggal J, Singh S, Kuchinic P, Butler P, Arora R. Utility of esmolol in thyroid crisis. Can J Clin Pharmacol 2006 Fall;13(3):e292-5.
Morelli A, Sanfilippo F, Romano SM. Esmolol in septic shock: old pathophysiological concept, an old drug, perhaps a new hemodynamic strategy in the right patient. J Thorac Dis 2016 Nov;8(11):3059-62.
Brown SM, Beesley SJ, Lanspa MJ, Grissom CK, Wilson EL, Parikh SM, et al. Esmolol infusion in patients with septic shock and tachycardia: a prospective, single-arm, feasibility study. Pilot Feasibility Stud 2018 Aug 3;4:132. doi: 10.1186/s40814-018-0321-5.
Stojiljković MP, Dobrić S, Lončar-Stojiljković D, Marenović T, Bošković B. [Use of esmolol in treatment of perioperative tachycardia and hypertension]. Pharmaca Iugoslav 1994;32(1):5-8. Serbian.
Lončar-Stojiljković D, Dobrić S, Stojiljković MP, Marenović T, Bošković B. [Esmolol as an adjunct to neurosurgical anaesthesia]. Arh Farm 1994;44(1-2):270-1. Serbian.
NCD Risk Factor Collaboration (NCD-RisC). Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys. Lancet 2019 Aug 24;394(10199):639-51.
Survila K, Lengen V, Cheng S, Niiranen TJ. Age of hypertension onset: overview of research and how to apply in practice. Curr Hypertens Rep 2020 Aug 27;22(9):68. doi: 10.1007/s11906-020-01071-z.
Lin PH, Zhou W, Kougias P, El Sayed HF, Barshes NR, Huyinh TT. Factors associated with hypotension and bradycardia after carotid angioplasty and stenting. J Vasc Surg 2007 Nov;46(5):846-53.
Wiest D. Esmolol. A review of its therapeutic efficacy and pharmacokinetic characteristics. Clin Pharmacokinet 1995 Mar;28(3):190-202.
Gerges FJ, Kanazi GE, Jabbour-Khoury SI. Anesthesia for laparoscopy: a review. J Clin Anesth 2006 Feb;18(1):67-78.
Vos JJ, Poterman M, Hannivoort LN, Renardel De Lavalette VW, Struys MM, Scheeren TW, et al. Hemodynamics and tissue oxygenation during balanced anesthesia with a high antinociceptive contribution: an observational study. Perioper Med (Lond) 2014 Oct 30;3:9. doi: 10.1186/2047-0525-3-9.
Vucevic M, Purdy GM, Ellis FR. Esmolol hydrochloride for management of the cardiovascular stress responses to laryngoscopy and tracheal intubation. Br J Anaesth 1992 May;68(5):529-30.
Wilson ES, McKinlay S, Crawford JM, Robb HM. The influence of esmolol on the dose of propofol required for induction of anaesthesia. Anaesthesia 2004 Feb;59(2):122-6.
Kang KJ, Yoo SH, Chung JH, Kim NS, Jung HS, Seo YH, et al. Dosing study of esmolol for reducing hemodynamic changes during lightwand intubation. Anesth Pain Med (Seoul) 2020 Oct 30;15(4):417-23.
Asouhidou I, Trikoupi A. Esmolol reduces anesthetic requirements thereby facilitating early extubation; a prospective controlled study in patients undergoing intracranial surgery. BMC Anesthesiol 2015 Nov 28;15:172. doi: 10.1186/s12871-015-0154-1.
Johansen JW, Flaishon R, Sebel PS. Esmolol reduces anesthetic requirement for skin incision during propofol/nitrous oxide/morphine anesthesia. Anesthesiology 1997 Feb;86(2):364-71.
Dhir R, Singh MR, Kaul TK, Tewari A, Oberoi R. Effect of intravenous esmolol on analgesic requirements in laparoscopic cholecystectomy. J Anaesthesiol Clin Pharmacol 2015 Jul-Sep;31(3):375-9.
Ergil J, Kavak Akelma F, Özkan D, Bumin Aydin G, Gürel A, Akinci M. Effects of pretreatment with esmolol and lidocaine on injection pain and rocuronium-induced withdrawal response. Turk J Med Sci 2015;45(4):959-63.
Mion G, Ruttimann M, Descraques C, Chabanne JP. [Bolus esmolol prior to tracheal intubation of the elderly patient]. Cah Anesthesiol 1992;40(2):95-9. French.
Singh PP, Dimich I, Sampson I, Sonnenklar N. A comparison of esmolol and labetalol for the treatment of perioperative hypertension in geriatric ambulatory surgical patients. Can J Anaesth 1992 Jul;39(6):559-62.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).